Showing results (1131-1140 of 1,211) with videos related to
Sort By:
Pageof 122
Circulation|September 5, 2020
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HFKieran F Docherty, Pardeep S Jhund, Inder Anand, et al.JAMA|December 4, 2020
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical TrialOrly Vardeny, KyungMann Kim, Jacob A Udell, et al.European Journal of Heart Failure|April 12, 2023
Geographic differences in patients with acute myocardial infarction in the PARADISE-MI trialJawad H Butt, Brian L Claggett, Zi M Miao, et al.American Heart Journal|September 5, 2024
Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trialsSheldon E Litwin, Jan Komtebedde, Barry A Borlaug, et al.Journal of the American College of Cardiology|June 12, 2024
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Francesco Cappelli, Christian Nitsche, et al.Journal of Cardiac Failure|March 17, 2024
Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4Ahmad Masri, Mark V Sherrid, Theodore P Abraham, et al.Circulation|August 27, 2022
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER TrialJawad H Butt, Pardeep S Jhund, Jan Belohlávek, et al.Plos One|July 24, 2020
Pre-existing traits associated with Covid-19 illness severityJoseph E Ebinger, Natalie Achamallah, Hongwei Ji, et al.JACC. Heart Failure|March 7, 2023
Dapagliflozin in Black and White Patients With Heart Failure Across the Ejection Fraction SpectrumJawad H Butt, Kieran F Docherty, Brian L Claggett, et al.Circulation|November 7, 2022
Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVERXiaowen Wang, Muthiah Vaduganathan, Brian L Claggett, et al.Pageof 122